Cite
Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy.
MLA
Werter, Inge M., et al. “Vγ9Vδ2-T Cells as Antigen Presenting Cells for INKT Cell Based Cancer Immunotherapy.” OncoImmunology, vol. 3, no. 9, Sept. 2014, p. N.PAG. EBSCOhost, https://doi.org/10.4161/21624011.2014.955343.
APA
Werter, I. M., Schneiders, F. L., Scotet, E., Verheul, H. M. W., de Gruijl, T. D., & van der Vliet, H. J. (2014). Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy. OncoImmunology, 3(9), N.PAG. https://doi.org/10.4161/21624011.2014.955343
Chicago
Werter, Inge M., Famke L. Schneiders, Emmanuel Scotet, Henk M.W. Verheul, Tanja D. de Gruijl, and Hans J. van der Vliet. 2014. “Vγ9Vδ2-T Cells as Antigen Presenting Cells for INKT Cell Based Cancer Immunotherapy.” OncoImmunology 3 (9): N.PAG. doi:10.4161/21624011.2014.955343.